Cargando…
Two 4N Cell-Cycle Arrests Contribute to Cisplatin-Resistance
Cisplatin is a platinum-based drug that is used for the treatment of a wide-variety of primary human cancers. However, the therapeutic efficacy of cisplatin is often limited by intrinsic or acquired drug resistance. An important goal, therefore, is to identify mechanisms that lead to cisplatin resis...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Public Library of Science
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3613405/ https://www.ncbi.nlm.nih.gov/pubmed/23560058 http://dx.doi.org/10.1371/journal.pone.0059848 |